4-[N-acryloyl-(4-chloro-2-fluorophenyl)amino]-6-[3-(morpholin-4-yl)propyloxy]-7-methoxyquinazoline

ID: ALA4475780

PubChem CID: 155537733

Max Phase: Preclinical

Molecular Formula: C25H26ClFN4O4

Molecular Weight: 500.96

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)N(c1ccc(Cl)cc1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12

Standard InChI:  InChI=1S/C25H26ClFN4O4/c1-3-24(32)31(21-6-5-17(26)13-19(21)27)25-18-14-23(22(33-2)15-20(18)28-16-29-25)35-10-4-7-30-8-11-34-12-9-30/h3,5-6,13-16H,1,4,7-12H2,2H3

Standard InChI Key:  NUEKSAINFNILIQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   42.6136  -18.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3153  -18.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6136  -19.2618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9038  -18.0277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0210  -18.4405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9038  -19.6704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3153  -17.2105    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.1980  -18.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1980  -19.2659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4490  -16.8019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3235  -19.6704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.7392  -17.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6403  -18.0401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.0293  -19.2618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0210  -16.8019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4490  -15.9806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2082  -17.2229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.7309  -15.5679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0210  -15.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4840  -18.0319    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.4840  -19.6745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.3461  -18.4528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0560  -18.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6362  -17.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9263  -18.4570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2164  -18.0442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9263  -16.8143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7741  -18.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7741  -19.2659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6073  -16.8024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6068  -15.9852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.8998  -17.2114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1919  -16.8032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7412  -18.0277    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   46.1563  -15.5713    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  2  0
  5  2  2  0
  6  3  2  0
  7  2  1  0
  8  4  1  0
  9  8  2  0
 10 12  1  0
 11  3  1  0
 12 15  2  0
 13 22  1  0
 14 11  2  0
 15  7  1  0
 16 18  1  0
 17 26  1  0
 18 19  2  0
 19 15  1  0
 20  8  1  0
 21  9  1  0
 22 23  1  0
 23 28  1  0
 24 13  1  0
 25 13  1  0
 26 25  1  0
 27 24  1  0
 28 20  1  0
 29 21  1  0
  6  9  1  0
 14  5  1  0
 10 16  2  0
 27 17  1  0
  7 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  2  0
 12 34  1  0
 16 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475780

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.96Molecular Weight (Monoisotopic): 500.1627AlogP: 4.38#Rotatable Bonds: 9
Polar Surface Area: 77.02Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.84CX LogP: 3.83CX LogD: 3.72
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -1.39

References

1. Wu KD, Chen GS, Liu JR, Hsieh CE, Chern JW..  (2019)  Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors.,  10  (1): [PMID:30655941] [10.1021/acsmedchemlett.8b00270]

Source